Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
06/2014
06/11/2014EP2739652A1 Cahgt1p inhibitors for use in the treatment of candidiasis
06/11/2014EP2739651A1 Anti-polyubiquitin antibodies and methods of use
06/11/2014EP2739650A2 Bovine polyclonal antibody specific for human tnf
06/11/2014EP2739358A1 Methods of treating cancer using pd-1 axis binding antagonists and mek inhibitors
06/11/2014EP2739311A1 Method for treating bone gap defects
06/11/2014EP2739310A1 Improved methods and compositions for modulation of olfml3 mediated angiogenesis
06/11/2014CN1849391B Nitrilases, nucleic acids encoding them and methods for making and using them
06/11/2014CN1757724B Use of multiple recombination sites with unique specificity in recombinational cloning
06/11/2014CN103857700A Tandem FC bispecific antibodies
06/11/2014CN103857699A Multivalent and monovalent multispecific complexes and their uses
06/11/2014CN103857698A Antibodies to 25-hydroxyvitamin D2 and D3 and uses thereof
06/11/2014CN103857697A Peptide or arrangement of peptides forming a staphylococcus aureus epitope binding site
06/11/2014CN103857696A Antibodies that bind integrin alpha-v beta-8
06/11/2014CN103857691A Selective anti-hla antibody removal device and methods of production and use thereof
06/11/2014CN103849604A Hybridoma cell strain ST03, anti-aflatoxin biosynthesis precursor ST monoclonal antibody and application thereof
06/11/2014CN103849603A Preparation and application of human HCRCN 81 protein and mouse anti-human monoclonal antibody
06/11/2014CN103848917A Survivin-MUC1 fusion protein, and coding gene and applications thereof
06/11/2014CN103848916A Preparation method, coding sequences and use of anti-CP4 5-enolpyruvyl-shikimate-3-phosphate synthase (EPSPS) monoclonal antibody
06/11/2014CN103848915A Preparation and application of novel anti-rabies virus glycoprotein human-derived genetically-engineered antibody
06/11/2014CN103848888A Antigenic peptides and antibodies thereof of human complement C1q/TNF alpha (tumor necrosis factor alpha) related protein-2 (hCTRP2)
06/11/2014CN103114079B Preparation of serologic H-Y antigen gene DBY antibody and XY sperm immune sorting method thereof
06/11/2014CN103012590B Anti-CD20 monoclonal antibody, preparation method and application thereof
06/11/2014CN102621323B Method for detecting 6-methylmercaptopurine
06/11/2014CN102617729B Tacrolimus immunogen, anti-tacrolimus specific antigen and tacrolimus detection reagent
06/11/2014CN102482357B Humanized anti-cdcp1 antibodies
06/11/2014CN101970489B Monoclonal antibodies that bind to hgm-csf and medical compositions comprising same
06/11/2014CN101932605B Compositions and methods for inhibiting tumor progression
06/11/2014CN101918447B Binding molecules to the human OX40 receptor
06/11/2014CN101855553B Predictive markers for ovarian cancer
06/11/2014CN101687922B Methods of treating ophthalmic diseases
06/11/2014CN101484182B Methods for generating stably linked complexes composed of homodimers, homotetramers or dimers of dimers and uses
06/11/2014CN101148474B Human resource vessel endothelium growth factor monoclonal antibody and preparation method thereof
06/10/2014US8748587 Molecules and methods for modulating TMEM16A activities
06/10/2014US8748585 Antibodies that bind to OX40 and their uses
06/10/2014US8748581 Anti-IL-6R polypeptides and pharmaceutical compositions thereof
06/10/2014US8748580 Device for enhancing immunostimulatory capabilities of T-cells
06/10/2014US8748395 Cell-permeable peptide inhibitors of the JNK signal transduction pathway
06/10/2014US8748380 Albumin variants
06/10/2014US8748373 Hepatitis B virus compositions and methods of use
06/10/2014US8748371 Nuclear targeting sequences
06/10/2014US8748175 Antibodies specifically binding to the epidermal growth factor receptor
06/10/2014US8748173 Monoclonal antibodies specific for anthrax spores and peptides derived from the antibodies thereof
06/10/2014US8748151 Clostridial neurotoxins with altered persistency
06/10/2014US8748131 Chimeric neuregulins and method of making and use thereof
06/10/2014US8748115 PCSK9 immunoassay
06/10/2014US8748107 Isolated antibodies which bind to CXC chemokine receptor 4
06/10/2014US8747864 Staphylococcus aureus proteins and nucleic acids
06/10/2014US8747857 Calicheamicin derivative-carrier conjugates
06/10/2014US8747856 Antigen binding fragments of an antibody for use in treating or diagnosing ocular diseases
06/10/2014US8747855 Anti human immunodeficiency antibodies and uses thereof
06/10/2014US8747854 Methods of treating moderate to severe hidradenitis suppurativa with anti-TNF-alpha antibodies
06/10/2014US8747851 Anti-CD33 antibodies and methods for treatment of acute myeloid leukemia using the same
06/10/2014US8747843 Method of treatment and bioassay involving macrophage migration inhibitory factor (MIF) as cardiac-derived myocardial depressant factor
06/10/2014CA2745618C Anti-ferroportin 1 monoclonal antibodies and uses thereof
06/10/2014CA2711863C Antibody directed against pcrv
06/10/2014CA2605759C Antibodies directed against amyloid-beta peptide and methods using same
06/10/2014CA2507373C Use of soluble forms of cd83 and nucleic acids encoding them for the treatment or prevention of diseases
06/10/2014CA2495100C Tissue specific expression of exogenous proteins in transgenic chickens
06/10/2014CA2482810C Teneurin c-terminal associated peptides (tcap) and methods and uses thereof
06/10/2014CA2482634C Diagnostic and therapeutic use of kremen 1 and 2, inhibitors of the canonical wnt-signal transduction
06/10/2014CA2300364C Prostate tumor polynucleotide and antigen compositions
06/05/2014WO2014085676A1 Ron compositions and methods of use thereof
06/05/2014WO2014085654A1 Anti-vegf antibodies and their uses
06/05/2014WO2014085637A1 New lantibiotic derivatives and a process for their preparation
06/05/2014WO2014085596A1 MONOCLONAL ANTIBODIES AGAISNT ACTIVATED PROTEIN C (aPC)
06/05/2014WO2014084607A1 Ch3 domain variant pair inducing formation of heterodimer of heavy chain constant region of antibody at high efficiency, method for preparing same, and use thereof
06/05/2014WO2014083861A1 Method for separating target substance-receptor complex and free receptors
06/05/2014WO2014083637A1 Method for separating target-receptor complex and free receptor
06/05/2014WO2014083379A1 Use of anti-fcyri and/or anti-fcyriia antibodies for treating arthritis, inflammation, thrombocytopenia and allergic shock
06/05/2014WO2014083208A1 Binding proteins comprising at least two repeat domains against her2
06/05/2014WO2014083040A2 Progranulin as marker for autoimmune disorders
06/05/2014WO2014083006A1 RECOMBINANT HUMAN IgM-ANTIBODY EFFECTIVE AGAINST CANCER CELLS
06/05/2014WO2014083004A1 Removal of cancer cells by circulating virus-specific cytotoxic t-cells using cancer cell targeted mhc class i comprising multi-function proteins
06/05/2014WO2014082179A1 Engineered immunoglobulin heavy chain-light chain pairs and uses thereof
06/05/2014WO2014071503A8 Identification of the dcps gene on 11q24.2, which encodes the human decapping enzyme scavenger, in non-syndromic autosomal recessive mental retardation, diagnostic probes thereof and methods of identifying subjects with same
06/05/2014WO2014059442A3 Antibody based reagents that specifically recognize toxic oligomeric forms of tau
06/05/2014WO2014058924A3 Antibodies recognizing alpha-synuclein
06/05/2014WO2014055897A3 Human monoclonal anti-pd-l1 antibodies and methods of use
06/05/2014WO2014037899A3 Il-18 binding molecules
06/05/2014WO2014036412A3 A method for treating melanoma using a herpes simplex virus and an immune checkpoint inhibitor
06/05/2014WO2013154206A9 Anti-fgfr2 antibody
06/05/2014WO2007141778A3 Development of follicle stimulating hormone agonists and antagonists in fish
06/05/2014US20140157443 Methods and compositions for detecting and modulating a novel mtor complex
06/05/2014US20140155585 Haptens of risperidone and paliperidone
06/05/2014US20140155584 Conjugated anti-cd38 antibodies
06/05/2014US20140155583 Monoclonal antibodies and single chain antibody fragments against cell-surface prostate specific membrane antigen
06/05/2014US20140155582 Novel anti-human ngf antibody
06/05/2014US20140155581 Methods For Making Multimeric Polypeptides
06/05/2014US20140155580 Transgenic aves producing human polyclonal antibodies
06/05/2014US20140155579 Dual specificity antibodies and methods of making and using
06/05/2014US20140154804 Method of targeting specific cell populations using cell-binding agent maytansinoid conjugates linked via a non-cleavable linker, said conjugates and methods of making said conjugates
06/05/2014US20140154770 Chemically Modified Graphene
06/05/2014US20140154743 Methods and materials for enhancing functional protein expression in bacteria
06/05/2014US20140154739 Methods for selecting eukaryotic cells expressing a heterologous protein
06/05/2014US20140154715 Monoclonal antibodies specific for beta-amyloid x-37 and uses thereof
06/05/2014US20140154705 Antibodies to oxidized ldl
06/05/2014US20140154704 Monoclonal Antibodies with Specficity for Fetal Erythroid Cells
06/05/2014US20140154699 Monoclonal Antibodies which Specifically Recognize Human Liver-Carboxylesterase 1, Hybridoma Cell Lines which Produce Monoclonal Antibodies, and Uses Thereof
06/05/2014US20140154307 Inhibition of factor b, the alternative complement pathway and methods related thereto
06/05/2014US20140154273 Anthracycline-Antibody Conjugates for Cancer Therapy
1 ... 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 ... 1494